Hormone Therapy Boosts Weight Loss Drug Results by 35%

For millions of women navigating menopause, a new study offers unexpected hope for managing stubborn weight gain.

Researchers at Mayo Clinic discovered that postmenopausal women taking hormone therapy alongside tirzepatide, a popular FDA-approved weight loss drug, lost significantly more weight than those using the drug alone. Women in the hormone therapy group lost an average of 19.2% of their body weight compared to 14.0% in the non-hormone group.

The study followed 120 postmenopausal women who were overweight or obese for at least 12 months. Forty of them used hormone therapy to treat symptoms like hot flashes and night sweats while taking tirzepatide, while 80 took the drug without hormones.

The results, published in The Lancet Obstetrics, Gynaecology, & Women's Health, suggest a new path forward for addressing weight-related health risks that increase after menopause. These include cardiovascular disease and Type 2 diabetes, both linked to the hormonal changes women experience during this life stage.

Dr. Regina Castaneda, the study's first author, emphasized the potential for more personalized treatment approaches. "This study provides important insights for developing more effective and personalized strategies for managing cardiometabolic risk in postmenopausal women," she said.

Researchers believe estrogen in hormone therapy may enhance how tirzepatide suppresses appetite, though they stress this is still unproven. Another possibility is that hormone therapy simply helps women feel better by improving sleep and reducing uncomfortable symptoms, making it easier to stick with healthy eating and exercise.

Outside experts urge caution in interpreting the results. Dr. Gillian Goddard, an endocrinologist at NYU Grossman School of Medicine, noted that women taking estrogen may already be healthier overall. They might be more likely to maintain diet and exercise routines, which could explain the extra weight loss.

The study was observational, meaning it shows a link but cannot prove hormone therapy directly caused the additional weight loss. Dr. Maria Daniela Hurtado Andrade, the study's senior author, acknowledged this limitation. "Because this was not a randomized trial, we cannot say hormone therapy caused additional weight loss," she said.

Experts agree the combination appears safe for most women, though hormone therapy isn't recommended for everyone. Women with a history of certain cancers, blood clots, or other health risks should consult their doctors before considering this approach.

Why This Inspires

This research represents more than just numbers on a scale. For years, postmenopausal women have faced frustrating weight gain despite their best efforts, often feeling overlooked by medical research focused on other populations.

This study acknowledges their specific challenges and searches for solutions tailored to their bodies and life stage. It suggests that what works for younger people or men might not be the complete answer for postmenopausal women.

Future randomized trials will confirm whether the combination truly delivers better results and improves overall heart and metabolic health. If proven effective, this approach could help millions of women navigate menopause with better health outcomes and renewed confidence.